Teladoc Health (TDOC) CFO Michael Grasher Receives RSU Award

What Happened Michael F. Grasher, Chief Financial Officer of Teladoc Health (TDOC), received a grant of 239,616 restricted stock units (RSUs) on 2026-09-01. The award is reported as a derivative acquisition (code A) at a grant price of $0.00. These RSUs are contingent rights to receive common stock in the future rather than an immediate cash purchase or sale.

Key Details

• Transaction date and type: 2026-09-01 — Award/Grant of RSUs (code A).
• Amount: 239,616 restricted stock units reported as acquired at $0.00 (derivative).
• Shares owned after transaction: Not specified in this Form 4 filing.
• Footnotes:
  • F1 — Each RSU represents a contingent right to receive one share of TDOC common stock.
  • F2 — Vesting schedule: half vests on the first anniversary of the grant; the remainder vests in six substantially equal quarterly installments thereafter.
• Filing timeliness: Report filed with a period of report 2026-09-01 (no late filing indicated in the supplied data).

Context RSU grants are a common form of executive compensation and do not represent an immediate market purchase or sale. The award grants the right to receive shares in the future subject to vesting conditions; until vested and settled, these units are not transferable shares. This filing reports the grant itself, not any subsequent sale, withholding, or conversion of the RSUs.